BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile

BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
32 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

BioNano Genomics, Inc. (BioNano) is a medical company that offers biotechnology research. The company develops and provides technology platform to analyze the segments of genomic DNA and other structural variations. Its products include iryschip, iryssolve computational solutions, irysprep reagents, irys instrument and irysview software. BioNanos proprietary Irys technology provides single molecule analysis of DNA. The company's irysprep reagent kit optimizes labeling reagents for accurate genome maps and supports for DNA extraction from various sample sources. It serves researchers and clinicians in life science industry.

BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summar

  
Source:
Document ID
GDME94704D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
BioNano Genomics, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201642
BioNano Genomics, Inc., Medical Equipment Deals By Type, 2010 to YTD 201661
BioNano Genomics, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201671
BioNano Genomics, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201681
BioNano Genomics, Inc., Medical Equipment, Deals Summary, 2010 to YTD 201691
BioNano Genomics, Inc., Medical Equipment, Deal Details109
  Venture Financing101
    BioNano Genomics Raises USD53 Million in Series C Venture Financing102
    BioNano Genomics Raises USD68.4 Million in Venture Financing121
    BioNano Genomics Raises USD5 Million in Venture Financing131
    BioNano Genomics Raises US$10 Million In Venture Financing141
    BioNano Genomics Raises US$10 Million In Series B-1 Financing151
    BioNano Genomics Raises US$8.8 Million In Venture Financing161
    BioNanomatrix Secures US$23.3 Million In Series B Equity Financing172
BioNano Genomics, Inc. - Key Competitors191
Key Employees201
Locations And Subsidiaries211
  Head Office211
Recent Developments221
Corporate Communications221
Sep 08, 2016: BioNano Elects David Barker, Ph.D., Former Chief Scientific Officer of Illumina, as Chairman of the Board221
Mar 26, 2015: BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer231
Product News241
Jan 11, 2016: Data Highlighted From 3 Studies Demonstrate Complementarity of BioNano Genomics Next-Generation Mapping to Sequencing242
Jan 07, 2016: BioNano Genomics Announces 32 Posters and Workshops Supporting Next-Generation Mapping to be Presented at PAG XXIV Conference261
Jan 06, 2016: Study Shows How CRISPR Labeling Further Expands BioNano Genomics Next-Generation Mapping Applications271
Jan 05, 2016: BioNano Genomics Highlights Study Using Next-Generation Mapping for 7-Fold Improvement in Structural Variation Detection Versus NGS281
Feb 24, 2015: BioNano Hits Scientific Milestone: 100 Unique Species Genetically Mapped and Analyzed291
Feb 09, 2015: Research Documents Rapid Detection of Structural Variation in a Human Genome Using BioNano's Irys System301
Clinical Trials311
Jan 05, 2016: BioNano Genomics Highlights Study Using Next-Generation Mapping for 7-Fold Improvement in Structural Variation Detection Versus NGS311
Appendix321
  Methodology321
  About GlobalData321
  Contact Us321
  Disclaimer321

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/BioNano-Genomics-Inc-Medical-Equipment-Deals-and-Alliances-Profile-2148-3640>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). BioNano Genomics, Inc. - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/BioNano-Genomics-Inc-Medical-Equipment-Deals-and-Alliances-Profile-2148-3640>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research